81 related articles for article (PubMed ID: 1678788)
1. Nonrandom distribution of N-myc oncogene genotypes in neuroblastoma.
Waber PG; Bowcock AM; Arencibia-Mireles O; Nisen PD
J Natl Cancer Inst; 1991 Aug; 83(15):1085-8. PubMed ID: 1678788
[TBL] [Abstract][Full Text] [Related]
2. Amplified allele of the human N-myc oncogene in neuroblastomas.
Yamada M; Kurosawa H; Nakagawa Y; Nakagome Y; Tsuda T; Higashi K
Jpn J Cancer Res; 1988 Jun; 79(6):670-3. PubMed ID: 2900826
[TBL] [Abstract][Full Text] [Related]
3. Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas.
Westermann F; Muth D; Benner A; Bauer T; Henrich KO; Oberthuer A; Brors B; Beissbarth T; Vandesompele J; Pattyn F; Hero B; König R; Fischer M; Schwab M
Genome Biol; 2008 Oct; 9(10):R150. PubMed ID: 18851746
[TBL] [Abstract][Full Text] [Related]
4. Retrospective study on amplification of N-myc and c-myc genes in pediatric solid tumors and its association with prognosis and tumor differentiation.
Tsuda H; Shimosato Y; Upton MP; Yokota J; Terada M; Ohira M; Sugimura T; Hirohashi S
Lab Invest; 1988 Sep; 59(3):321-7. PubMed ID: 3411933
[TBL] [Abstract][Full Text] [Related]
5. Preferential amplification of the paternal allele in neuroblastomas with N-myc amplification.
Cheng JM; Hiemstra JL; Schneider SS; Kaufman BA; Naumova A; Cheung NK; Cohn SL; Diller L; Sapienza C; Brodeur GM
Prog Clin Biol Res; 1994; 385():43-9. PubMed ID: 7972236
[TBL] [Abstract][Full Text] [Related]
6. Restriction fragment length polymorphisms of the human N-myc gene: relationship to gene amplification.
Kurosawa H; Yamada M; Nakagome Y
Oncogene; 1987; 2(1):85-90. PubMed ID: 2894002
[TBL] [Abstract][Full Text] [Related]
7. Rare MYC-amplified Neuroblastoma With Large Cell Histology.
Matsuno R; Gifford AJ; Fang J; Warren M; Lukeis RE; Trahair T; Sugimoto T; Marachelian A; Asgharzadeh S; Maris JM; Ikegaki N; Shimada H
Pediatr Dev Pathol; 2018; 21(5):461-466. PubMed ID: 29426276
[TBL] [Abstract][Full Text] [Related]
8. Ability of circular extrachromosomal DNA molecules to carry amplified MYCN proto-oncogenes in human neuroblastomas in vivo.
VanDevanter DR; Piaskowski VD; Casper JT; Douglass EC; Von Hoff DD
J Natl Cancer Inst; 1990 Dec; 82(23):1815-21. PubMed ID: 2250296
[TBL] [Abstract][Full Text] [Related]
9. Preferential amplification of the paternal allele of the N-myc gene in human neuroblastomas.
Cheng JM; Hiemstra JL; Schneider SS; Naumova A; Cheung NK; Cohn SL; Diller L; Sapienza C; Brodeur GM
Nat Genet; 1993 Jun; 4(2):191-4. PubMed ID: 8102299
[TBL] [Abstract][Full Text] [Related]
10. Differences of L-myc polymorphic patterns of neuroblastoma in patients under 1 year versus older ages: a preliminary report.
Murakami T; Ohmori H; Katoh T; Nakamura H; Tsuda T; Shan RC; Akiya S; Nakagawara A; Higashi K
J Pediatr Surg; 1992 Nov; 27(11):1442-6. PubMed ID: 1362216
[TBL] [Abstract][Full Text] [Related]
11. Enhanced expression of N-myc messenger RNA in neuroblastomas found by mass screening.
Matsunaga T; Shirasawa H; Hishiki T; Yoshida H; Kouchi K; Ohtsuka Y; Kawamura K; Etoh T; Ohnuma N
Clin Cancer Res; 2000 Aug; 6(8):3199-204. PubMed ID: 10955804
[TBL] [Abstract][Full Text] [Related]
12. Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma.
Bourhis J; De Vathaire F; Wilson GD; Hartmann O; Terrier-Lacombe MJ; Boccon-Gibod L; McNally NJ; Lemerle J; Riou G; Bénard J
Cancer Res; 1991 Jan; 51(1):33-6. PubMed ID: 1988094
[TBL] [Abstract][Full Text] [Related]
13. Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastomas.
Nakagawara A; Kadomatsu K; Sato S; Kohno K; Takano H; Akazawa K; Nose Y; Kuwano M
Cancer Res; 1990 May; 50(10):3043-7. PubMed ID: 2185879
[TBL] [Abstract][Full Text] [Related]
14. Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification.
Caron H; van Sluis P; van Hoeve M; de Kraker J; Bras J; Slater R; Mannens M; Voûte PA; Westerveld A; Versteeg R
Nat Genet; 1993 Jun; 4(2):187-90. PubMed ID: 8102298
[TBL] [Abstract][Full Text] [Related]
15. ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic value.
Vandesompele J; Edsjö A; De Preter K; Axelson H; Speleman F; Påhlman S
Oncogene; 2003 Jan; 22(3):456-60. PubMed ID: 12545167
[TBL] [Abstract][Full Text] [Related]
16. Coamplification of the L-myc and N-myc oncogenes in a neuroblastoma cell line.
Jinbo T; Iwamura Y; Kaneko M; Sawaguchi S
Jpn J Cancer Res; 1989 Apr; 80(4):299-301. PubMed ID: 2501244
[TBL] [Abstract][Full Text] [Related]
17. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
Martinsson T; Sjöberg RM; Hedborg F; Kogner P
Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
[TBL] [Abstract][Full Text] [Related]
18. Amplification and rearrangement of DNA sequences from the chromosomal region 2p24 in human neuroblastomas.
Shiloh Y; Korf B; Kohl NE; Sakai K; Brodeur GM; Harris P; Kanda N; Seeger RC; Alt F; Latt SA
Cancer Res; 1986 Oct; 46(10):5297-301. PubMed ID: 3756879
[TBL] [Abstract][Full Text] [Related]
19. WDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in Neuroblastoma.
Sun Y; Bell JL; Carter D; Gherardi S; Poulos RC; Milazzo G; Wong JW; Al-Awar R; Tee AE; Liu PY; Liu B; Atmadibrata B; Wong M; Trahair T; Zhao Q; Shohet JM; Haupt Y; Schulte JH; Brown PJ; Arrowsmith CH; Vedadi M; MacKenzie KL; Hüttelmaier S; Perini G; Marshall GM; Braithwaite A; Liu T
Cancer Res; 2015 Dec; 75(23):5143-54. PubMed ID: 26471359
[TBL] [Abstract][Full Text] [Related]
20. [Activation of ras and myc proto-oncogenes in human breast carcinoma and neuroblastoma].
Kniazev PG; Schafer R; Willecke K; Pluzhnikova GF; Serova OM
Mol Biol (Mosk); 1986; 20(5):1236-43. PubMed ID: 3022123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
